HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Crisponi, G. Articles by Faa, G. Search for Related Content PubMed PubMed Citation Articles by Crisponi, G. Articles by Faa, G. Related Collections Molecular Diagnostics and Genetics Endocrinology and Metabolism

Does Iron Concentration in a Liver Needle Biopsy Accurately Reflect Hepatic Iron Burden in ß-Thalassemia?

¹ Dipartimento di Chimica Inorganica ed Analitica, Università di Cagliari, Complesso Universitario di Monserrato, 09042 Monserrato-Cagliari, Italy

² Dipartimento di Citomorfologia, Divisione di Anatomia Patologica, Università di Cagliari, Via Ospedale 60, 09124 Cagliari, Italy
^a author for correspondence: fax 39-0706754478, e-mail crisponi@unica.it

ß-Thalassemia major is an autosomal recessive disease characterized by absent or decreased synthesis of the ß-globin gene (1). Thalassemic children, estimated at 100 000 worldwide, are affected by chronic anemia and need regular blood transfusion (2). Because of the limited capacity of iron excretion in humans, the iron in transfused red cells accumulates in the body. The liver, heart, and pancreas are the target organs of iron-induced injury; therefore, the major pathological manifestations observed in ß-thalassemia major are chronic liver disease, evolving to cirrhosis, and dilative cardiomyopathy, both characterized by severe iron deposition (3)(4). The dangerous effects of iron excess can be managed by administration of chelators capable of removing iron from transferrin, ferritin, and other iron stores (5)(6)(7). Determination of the hepatic iron concentration (HIC) is one of the most valid procedures in assessing real body iron burden (8)(9)(10), which is important for adjusting each patient’s chelation therapy over the years. HIC usually is measured on one part of a needle biopsy core, and the measured value is considered representative of the iron concentration in the whole liver (11). In 1995, a study by our group (3) first showed that iron is unevenly distributed in the livers of ß-thalassemic patients, and therefore, the iron content determined in a small liver fragment should be interpreted with caution because it cannot be considered a true representation of the mean HIC. These data were confirmed by us (12)(13)(14) and by other authors (15), who reported differences in HIC measurements on liver biopsy specimens.

Recently, a striking difference in HIC was found in biopsy samples from cirrhotic livers (range, 60–2851 µg/g . . . [Full Text of this Article]

Acknowledgments

References

The following articles in journals at HighWire Press have cited this article:

				J. C. Wood, C. Enriquez, N. Ghugre, J. M. Tyzka, S. Carson, M. D. Nelson, and T. D. Coates MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients Blood, August 15, 2005; 106(4): 1460 - 1465. [Abstract] [Full Text] [PDF]